Literature DB >> 25183197

Tumor suppressor role of protein 4.1B/DAL-1.

Zi Wang1, Ji Zhang, Mao Ye, Min Zhu, Bin Zhang, Mridul Roy, Jing Liu, Xiuli An.   

Abstract

Protein 4.1B/DAL-1 is a membrane skeletal protein that belongs to the protein 4.1 family. Protein 4.1B/DAL-1 is localized to sites of cell-cell contact and functions as an adapter protein, linking the plasma membrane to the cytoskeleton or associated cytoplasmic signaling effectors and facilitating their activities in various pathways. Protein 4.1B/DAL-1 is involved in various cytoskeleton-associated processes, such as cell motility and adhesion. Moreover, protein 4.1B/DAL-1 also plays a regulatory role in cell growth, differentiation, and the establishment of epithelial-like cell structures. Protein 4.1B/DAL-1 is normally expressed in multiple human tissues, but loss of its expression or prominent down-regulation of its expression is frequently observed in corresponding tumor tissues and tumor cell lines, suggesting that protein 4.1B/DAL-1 is involved in the molecular pathogenesis of these tumors and acts as a potential tumor suppressor. This review will focus on the structure of protein 4.1B/DAL-1, 4.1B/DAL-1-interacting molecules, 4.1B/DAL-1 inactivation and tumor progression, and anti-tumor activity of the 4.1B/DAL-1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25183197     DOI: 10.1007/s00018-014-1707-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  110 in total

1.  Immunolocalization of protein 4.1B in the rat digestive system.

Authors:  Nobuo Terada; Nobuhiko Ohno; Hisashi Yamakawa; Takeshi Baba; Yasuhisa Fujii; Osamu Ohara; Shinichi Ohno
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

Review 2.  Topographical significance of membrane skeletal component protein 4.1 B in mammalian organs.

Authors:  Nobuo Terada; Nobuhiko Ohno; Hisashi Yamakawa; Osamu Ohara; Shinichi Ohno
Journal:  Anat Sci Int       Date:  2005-06       Impact factor: 1.741

3.  Interaction of membrane skeletal protein, protein 4.1B and p55, and sodium bicarbonate cotransporter1 in mouse renal S1-S2 proximal tubules.

Authors:  Nobuo Terada; Nobuhiko Ohno; Sei Saitoh; George Seki; Masayuki Komada; Tatsuo Suzuki; Hisashi Yamakawa; Manoocher Soleimani; Shinichi Ohno
Journal:  J Histochem Cytochem       Date:  2007-08-21       Impact factor: 2.479

4.  Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation.

Authors:  Robin Kuns; Joseph L Kissil; Irene F Newsham; Tyler Jacks; David H Gutmann; Larry S Sherman
Journal:  Oncogene       Date:  2005-09-29       Impact factor: 9.867

5.  A 130-kDa protein 4.1B regulates cell adhesion, spreading, and migration of mouse embryo fibroblasts by influencing actin cytoskeleton organization.

Authors:  Jie Wang; Jinlei Song; Chao An; Wenji Dong; Jingxin Zhang; Changcheng Yin; John Hale; Anthony J Baines; Narla Mohandas; Xiuli An
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

6.  The 30-kD domain of protein 4.1 mediates its binding to the carboxyl terminus of pICln, a protein involved in cellular volume regulation.

Authors:  C J Tang; T K Tang
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

Review 7.  Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation.

Authors:  Chun-Xiao Sun; Victoria A Robb; David H Gutmann
Journal:  J Cell Sci       Date:  2002-11-01       Impact factor: 5.285

8.  Role of Gab1 in UV-induced c-Jun NH2-terminal kinase activation and cell apoptosis.

Authors:  Yingqing Sun; Jing Yuan; Houqi Liu; Zhongqing Shi; Kelly Baker; Kristiina Vuori; Jie Wu; Gen-Sheng Feng
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis.

Authors:  Victoria A Robb; Wen Li; Philippe Gascard; Arie Perry; Narla Mohandas; David H Gutmann
Journal:  Neurobiol Dis       Date:  2003-08       Impact factor: 5.996

10.  The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells.

Authors:  Wei Jiang; Irene F Newsham
Journal:  Mol Cancer       Date:  2006-01-18       Impact factor: 27.401

View more
  12 in total

1.  Protein 4.1R negatively regulates CD8+ T-cell activation by modulating phosphorylation of linker for activation of T cells.

Authors:  Dandan Fan; Jianhui Li; Yi Li; Yaxin Guo; Xiaolin Zhang; Wen Wang; Xiaojie Liu; Jingjing Liu; Liping Dai; Liguo Zhang; Qiaozhen Kang; Zhenyu Ji
Journal:  Immunology       Date:  2019-06-24       Impact factor: 7.397

2.  Unreported intrinsic disorder in proteins: Disorder emergency room.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-04-22

3.  DAL-1/4.1B promotes the uptake of exosomes in lung cancer cells via Heparan Sulfate Proteoglycan 2 (HSPG2).

Authors:  Shuai Zhang; Min Guo; Tingting Guo; Mingyan Yang; Jiaqi Cheng; Chenyang Cui; Jie Kang; Jiajia Wang; Yuanru Nian; Wenjie Ma; Haibin Weng; Haibo Weng
Journal:  Mol Cell Biochem       Date:  2021-10-17       Impact factor: 3.396

4.  4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.

Authors:  Qin Yang; Min Zhu; Zi Wang; Hui Li; Weihua Zhou; Xiaojuan Xiao; Bin Zhang; Weixin Hu; Jing Liu
Journal:  Tumour Biol       Date:  2016-07-22

5.  Immunohistochemical study of the membrane skeletal protein, membrane protein palmitoylated 6 (MPP6), in the mouse small intestine.

Authors:  Akio Kamijo; Yurika Saitoh; Nobuhiko Ohno; Shinichi Ohno; Nobuo Terada
Journal:  Histochem Cell Biol       Date:  2015-10-26       Impact factor: 4.304

Review 6.  The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective.

Authors:  Chang-Hyun Lee; Chun Kee Chung; Jung Hun Ohn; Chi Heon Kim
Journal:  J Korean Neurosurg Soc       Date:  2016-02-29

Review 7.  Forecast of actin-binding proteins as the oncotarget in osteosarcoma - a review of mechanism, diagnosis and therapy.

Authors:  Yucheng Fu; Wei Yu; Hongliu Cai; Anwei Lu
Journal:  Onco Targets Ther       Date:  2018-03-20       Impact factor: 4.147

8.  Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.

Authors:  Zi Wang; Bianyin Ma; Hui Li; Xiaojuan Xiao; Weihua Zhou; Feng Liu; Bin Zhang; Min Zhu; Qin Yang; Yayue Zeng; Yang Sun; Shuming Sun; Yanpeng Wang; Yibin Zhang; Haibo Weng; Lixiang Chen; Mao Ye; Xiuli An; Jing Liu
Journal:  Oncotarget       Date:  2016-01-05

9.  Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.

Authors:  G Heller; T Topakian; C Altenberger; S Cerny-Reiterer; S Herndlhofer; B Ziegler; P Datlinger; K Byrgazov; C Bock; C Mannhalter; G Hörmann; W R Sperr; T Lion; C C Zielinski; P Valent; S Zöchbauer-Müller
Journal:  Leukemia       Date:  2016-05-23       Impact factor: 11.528

10.  LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p.

Authors:  Liying Zhu; Nenghong Yang; Juan Chen; Tao Zeng; Shaoying Yan; Yuyang Liu; Gangfeng Yu; Qiuxu Chen; Guiqin Du; Wei Pan; Xing Li; Huihao Zhou; Ailong Huang; Hua Tang
Journal:  Oncotarget       Date:  2017-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.